Hillsdale Investment Management Inc.

Position in PCRX — Pacira BioSciences, Inc.

CIK 1368465 Toronto, A6

Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$9,201,699

+$1,714,319 QoQ

Shares Held

362,700

+9.5% QoQ

Ownership

0.910%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#24

of 251 holders

Holding Since

Dec 2023

7 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Hillsdale Investment Management Inc. holds $42,212,910 across 9 Drug Manufacturers - Specialty & Generic names. PCRX ranks #2 (21.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	649,179	$11,237,288
2	PCRX	Pacira BioSciences, Inc. This page	362,700	$9,201,699
3	COLL	Collegium Pharmaceutical, Inc	191,600	$6,935,920
4	IRWD	Ironwood Pharmaceuticals Inc	1,250,428	$5,264,301
5	SUPN	Supernus Pharmaceuticals, Inc.	103,680	$4,822,156
6	ANIK	Anika Therapeutics, Inc.	138,821	$2,030,951
7	VTRS	Viatris Inc	117,650	$1,868,282
8	LQDA	Liquidia Corp	6,070	$483,961

All Filings in PCRX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,201,699	362,700	+9.5%	Shares	Sole	2026-08-12
2026-03-31	$7,487,380	331,300	+7.5%	Shares	Sole	2026-05-04
2025-12-31	$7,976,216	308,200	+34.5%	Shares	Sole	2026-02-10
2024-09-30	$3,449,460	229,200	+141.0%	Shares	Sole	2024-11-12
2024-06-30	$2,720,811	95,100	-34.6%	Shares	Sole	2024-08-13
2024-03-31	$4,248,588	145,400	+8.5%	Shares	Sole	2024-05-10
2023-12-31	$4,521,160	134,000	—	Shares	Sole	2024-02-09
No filing history on record for this holder in this stock.